| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/25/2009 | WO2009046863A3 Use of thymosin alpha 1 peptide or the combination with the human pancreatic polypeptide as a therapeutic agent |
| 06/25/2009 | WO2009040046A3 Use of stresscopin-related peptide as a therapeutic agent |
| 06/25/2009 | WO2009040021A3 Use of a peptide as a therapeutic agent |
| 06/25/2009 | WO2009033746A3 Use of a peptide as a therapeutic agent |
| 06/25/2009 | WO2008098396A3 Oxazolidinones and their use as hypocholesterolemic agents |
| 06/25/2009 | WO2008097497A3 Vegf pathway blockade |
| 06/25/2009 | WO2008046084A3 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 06/25/2009 | US20090163721 Crystalline solids of carvedilol and processes for their preparation |
| 06/25/2009 | US20090163593 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists; pain, Parkinson's disease, multiple sclerosis, or Huntington's chorea; asthma |
| 06/25/2009 | US20090163590 Process for producing refined avocado oil rich in triglycerides, and oil obtainable by said process |
| 06/25/2009 | US20090163580 Anti-aging composition containing resveratrol and method of administration |
| 06/25/2009 | US20090163556 Glycinamide derivatives as raf-kinase inhbitors |
| 06/25/2009 | US20090163552 Carboxyl- or hydroxyl-substituted benzimidazole derivatives |
| 06/25/2009 | US20090163542 5-ht7 receptor antagonists |
| 06/25/2009 | US20090163521 Novel Pyrazolopyrimidinone Derivatives |
| 06/25/2009 | US20090163515 Compounds Which Bind to the Active Site of Protein Kinase Enzymes |
| 06/25/2009 | US20090163506 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
| 06/25/2009 | US20090163497 Compounds Useful as Antagonists of CCR2 |
| 06/25/2009 | US20090163495 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 06/25/2009 | US20090163493 cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor |
| 06/25/2009 | US20090163487 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 06/25/2009 | US20090163481 Ppar-delta ligands and methods of their use |
| 06/25/2009 | US20090163480 Modified amino acids, pharmaceuticals containing these compounds and method for their production |
| 06/25/2009 | US20090163477 Phthalazinone derivatives |
| 06/25/2009 | US20090163473 (PYRIDO/THIENO)-[f]-OXAZEPINE-5-ONE DERIVATIVES |
| 06/25/2009 | US20090163472 Mineralocorticoid receptor antagonists and methods of use |
| 06/25/2009 | US20090163443 from the culture of Streptomyces vayuensis strain; Nonadeca-6-enoic acid-3-(hexadecyloxy-hydroxy-thiophosphoryloxy)-quinoxalin-2-yl ester, useful particularly for prevention of obesity and treatment of diabetes, sleep apnea, nervous system, cardiovascular and gastrointestinal disorders |
| 06/25/2009 | US20090163425 Peptide Inhibiting Angiotensin Converting Enzyme |
| 06/25/2009 | US20090162440 Sodium alginate microsphere vascular embolus containing water-soluble drug and preparation and application thereof |
| 06/25/2009 | US20090162381 Method for Treating Vascular Disorders |
| 06/25/2009 | US20090162357 Diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 06/25/2009 | US20090162343 Recombinant elastase proteins and methods of manufacturing and use thereof |
| 06/25/2009 | US20090162316 Liver targeted conjugates |
| 06/25/2009 | US20090162282 Substituted 4--piperidine-1-carboxylic acid esters as a2ar agonists |
| 06/25/2009 | DE102007061766A1 New 4-(4-cyano-2-thioaryl)-dihydro-pyrimidinone compounds are human neutrophil elastase inhibitor, useful for the treatment or prevention of e.g. pulmonary arterial hypertonia, acute lung injury and diseases of the cardiovascular system |
| 06/25/2009 | DE102007061764A1 Anellierte Cyanopyridine und ihre Verwendung Fused cyanopyridines and their use |
| 06/25/2009 | DE102007061763A1 Substituierte azabicyclische Verbindungen und ihre Verwendung Substituted azabicyclic compounds and their use |
| 06/25/2009 | DE102007061757A1 Substituierte 2-Phenylpyrimidin-5-carbonsäuren und ihre Verwendung Substituted 2-phenyl-pyrimidine-5-carboxylic acids and their use |
| 06/25/2009 | DE102007061756A1 Substituierte 4-Aminopyrimidin-5-carbonsäuren und ihre Verwendung Substituted 4-aminopyrimidine-5-carboxylic acids and their use |
| 06/25/2009 | CA2709579A1 Materials and methods for treatment of pathological ocular vascular proliferation |
| 06/25/2009 | CA2709187A1 4-imidazolidinones as kv1.5 potassium channel inhibitors |
| 06/25/2009 | CA2709186A1 4-imidazolidinones as kv1.5 potassium channel inhibitors |
| 06/25/2009 | CA2709068A1 Benzofuran anilide histone deacetylase inhibitors |
| 06/25/2009 | CA2708956A1 Compounds and methods for the treatment of vascular disease |
| 06/25/2009 | CA2708866A1 Bicyclic heterocyclic derivative |
| 06/24/2009 | EP2072522A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 06/24/2009 | EP2072519A1 Diaryl ketimine derivative |
| 06/24/2009 | EP2072082A2 N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3 sulfonamide as analgetic agent |
| 06/24/2009 | EP2072049A2 Solid valsartan pharmaceutical compositions |
| 06/24/2009 | EP2072046A1 Use of a hydrocarbon-containing preparation for preventing or treating cardiac-circulatory diseases, diabetes, osteoporosis and chronic liver failure |
| 06/24/2009 | EP1948654B1 5-amino-4-hydroxy-7- (imidazo [1,2-a] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
| 06/24/2009 | EP1611109A4 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 06/24/2009 | EP1483247B1 Aryl substituted pyrimidines and the use thereof |
| 06/24/2009 | EP1445258B1 Activator for peroxisome proliferator-activated receptor delta |
| 06/24/2009 | EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 06/24/2009 | CN100503611C New use of specific cyclolignans |
| 06/24/2009 | CN100503608C Deazapurines and uses thereof |
| 06/24/2009 | CN100503605C Benzimidazole derivative and its use as AII receptor antagonist |
| 06/24/2009 | CN100503602C Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503580C Irreversible inhibitor of tyrosine kinase |
| 06/24/2009 | CN100503574C Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 06/24/2009 | CN100503572C Caspase inhibitors and uses thereof |
| 06/24/2009 | CN100503560C Substituted cyclohexane derivatives |
| 06/24/2009 | CN100502937C Chinese medicine composition for treating cardiovascular disease and its preparing method |
| 06/24/2009 | CN100502919C Pill for treating varicosity and thrombophlebitis |
| 06/24/2009 | CN100502908C Use of medicine composition in preparing hypertension medicine |
| 06/24/2009 | CN100502901C Extraction method for effective parts of salvia |
| 06/24/2009 | CN100502874C Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 06/24/2009 | CN100502863C 2,4,5-trisubstituded thiazolyl derivatives and their anti-inflammatory activity |
| 06/24/2009 | CN100502861C Medicament inhibiting sodium/calcium exchange system |
| 06/24/2009 | CN100502857C Oral pharmaceutical composition for treating cardiovascular and cerebrovascular diseases and preparation method |
| 06/23/2009 | US7550597 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/23/2009 | US7550507 2-(alpha-hydroxypentyl) benzoate and its preparation and use |
| 06/23/2009 | US7550503 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550476 Condensed polycyclic compounds |
| 06/23/2009 | US7550475 Use of phosphodiesterase 4 inhibitors such as 6,7-dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene to treat asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550464 Use of phosphodiesterase 4 inhibitors such as 8,9-dimethoxy-6-phenyl-1,3,4,6,11,11a-hexahydro-2H -pyrazino[1,2-b]isoquinoline for treating asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550457 Therapy of vascular system diseases |
| 06/23/2009 | US7550257 Hyperpolarizing with potential-sensitive fluorescent dye and isoosmolar sodium-ion-free buffer, incubating, determining membrane potential, adding sodium, recording change in potential; voltage sensitive oxonol dyes; sodium channel modulators; high throughput screening; fluorescent imaging plate reader |
| 06/23/2009 | US7550142 Anti-integrin antibodies, compositions, methods and uses |
| 06/23/2009 | CA2551963C Pharmaceutical compositions and treatment of arteriosclerosis with cs-866 |
| 06/23/2009 | CA2535920C Method of stabilizing lipid-rich plaque and method of preventing rupture thereof |
| 06/23/2009 | CA2492804C Novel inhibitors of kinases |
| 06/23/2009 | CA2415042C Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure |
| 06/23/2009 | CA2405046C Stabilized pharmaceutical compositions comprising a calcium blocker and an alkaline material |
| 06/23/2009 | CA2389219C Dry powder compositions having improved dispersivity |
| 06/23/2009 | CA2350992C Preventive or therapeutic agents for myocarditis, dilated cardiomyopathy and heart failure comprising nf-kb inhibitors as active ingredients |
| 06/18/2009 | WO2009076664A1 Method and composition for treating a serotonin receptor-mediated condition |
| 06/18/2009 | WO2009076631A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 06/18/2009 | WO2009076580A2 Compositions and methods for the treatment and prevention of cardiovascular diseases |
| 06/18/2009 | WO2009076288A1 Dual-acting benzoimidazole derivative and their use as antihypertensive agents |
| 06/18/2009 | WO2009076105A2 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| 06/18/2009 | WO2009075835A1 CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1 |
| 06/18/2009 | WO2009075824A1 Methods for increasing endothelial progentior cells |
| 06/18/2009 | WO2009075349A1 Element retained in blood showing degradability selectively in tumor tissue |
| 06/18/2009 | WO2009075277A1 4-aminopyrimidine derivative and medicinal composition containing the compound |
| 06/18/2009 | WO2009074969A2 Spingosine-1-phosphate, analogues and antagonists for use as medicaments |
| 06/18/2009 | WO2009074733A2 Addition salts of angiotensine-converting enzyme inhibitors with no donor acids, method for preparing same and pharmaceutical compositions containing same |